Streetbeat News

Stock Prices

ABT

MDT

Shares of Medtronic plc. (NYSE:MDT) and Abbott Laboratories (NYSE:ABT) are trading lower after the U.S. Food and Drug Administration (FDA) established a Digital Health Advisory Committee. The committee will explore issues related to digital health technologies and will be fully operational in 2024. At the time of publication, shares of MDT were down 4.86% at $72.48 while shares of ABT were down 5.13% at $92.55.

Portfolio Pulse from Ryan Gustafson

October 11, 2023 | 7:08 pm

NFLX

Piper Sandler analyst Matt Farrell maintained a Neutral rating on Netflix Inc (NASDAQ:NFLX) and lowered the price target from $440 to $400 ahead of Q3 earnings. Farrell cited concerns over margins and leadership changes, particularly the departure of the advertising business leader. He also noted potential price increases on ad-free plans and the continuation of the paid-sharing roll-out. Morgan Stanley analyst Benjamin Swinburne also maintained an Equal-Weight rating on Netflix and lowered the price target from $450 to $430.

Portfolio Pulse from Anusuya Lahiri

October 11, 2023 | 7:07 pm

BCO

NCR

NCR Corporation's shares are trading higher following reports of a potential merger of its ATM business with Brink's Co., despite Brink's denying the speculation. NCR's CEO, Michael D. Hayford, is also retiring following the successful separation of NCR into NCR Atleos and NCR Voyix. The stock experienced above-average trading volume.

Portfolio Pulse from Ryan Gustafson

October 11, 2023 | 7:02 pm

GS

A significant bullish stance has been taken on Goldman Sachs Gr (NYSE:GS) as indicated by unusual options activity. The sentiment among big-money traders is split between 54% bullish and 45% bearish. Whales have been targeting a price range from $290.0 to $425.0 for Goldman Sachs Gr over the last 3 months. The price of GS is up 0.55% at $316.5. Analysts from Oppenheimer, Citigroup, Morgan Stanley, and JMP Securities have maintained their ratings on Goldman Sachs Gr with price targets ranging from $329 to $450.

Portfolio Pulse from Benzinga Insights

October 11, 2023 | 7:01 pm

BCDA

Over the past 3 months, 4 analysts have published their opinion on BioCardia (NASDAQ:BCDA) stock, all of them being bullish. The average price target is $6.5, implying significant upside from the current price of $0.3976. However, this average has decreased by 27.78% from the previous average price target of $9.00.

Portfolio Pulse from Benzinga Insights

October 11, 2023 | 7:00 pm

EXEL

14 analysts have provided ratings for Exelixis (NASDAQ:EXEL) in the last quarter, with an average price target of $25.64, indicating an upside from the current price of $21.57. The average price target has increased by 7.6% over the past month.

Portfolio Pulse from Benzinga Insights

October 11, 2023 | 7:00 pm

WEN

Analysts have provided various ratings for Wendy's (NASDAQ:WEN) within the last quarter, with 2 bullish, 6 somewhat bullish, and 5 indifferent. The average 12-month price target for Wendy's is $25.42, a decrease of 4.08% from the previous average price target of $26.50.

Portfolio Pulse from Benzinga Insights

October 11, 2023 | 7:00 pm

ULCC

Over the past 3 months, 12 analysts have published their opinion on Frontier Group Holdings (NASDAQ:ULCC) stock. The average price target for the stock is $9.29, a decrease of 30.93% from the previous average price target of $13.45. The analysts are evenly split between somewhat bullish and indifferent stances.

Portfolio Pulse from Benzinga Insights

October 11, 2023 | 7:00 pm

SHAK

In the last quarter, Shake Shack (NYSE:SHAK) has received 14 analyst ratings, with 3 being bullish, 1 somewhat bullish, and 10 indifferent. Over the past 3 months, 14 analysts have offered 12-month price targets for Shake Shack, with an average price target of $76.71, an increase of 8.21% from the previous average price target of $70.89.

Portfolio Pulse from Benzinga Insights

October 11, 2023 | 7:00 pm

PLUG

Plug Power CEO Andy Marsh appeared on CNBC to discuss the company's projections and the day's stock movement following revenue guidance.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2023 | 6:53 pm